Home Tags Posts tagged with "Journal of Commercial Biotechnology"

Journal of Commercial Biotechnology

The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited by Arlen Meyers.

The links below will take you to the abstract for each paper:

Volume 15, Issue 2

EditorialPDF
Arlen Meyers

Articles

Integrating virtual internships into online classroomsPDF
Richard Conroy, Rana Khan
The implementation of a proseminar course to lead change in the MS.MBA biotechnology programme at Johns Hopkins UniversityPDF
Lynn Johnson Langer
Creating bioentrepreneurs: How graduate student organisations foster science entrepreneurshipPDF
Justin T Brown, Andrew C Kant
Best practices for developing university bioentrepreneurship education programmesPDF
Thomas Crispeels, Oliver Uecke, Marc Goldchstein, Michael Schefczyk
Team-based learning in Keck Graduate Institute’s professional Master of Bioscience programmePDF
Jane G Tirrell, Thomas Gregory Dewey
Creating alternatives in sciencePDF
Nicole G Gravagna
Building the future biotechnology workforce: A University of Houston modelPDF
Rupa S Iyer, William E Fitzgibbon
The Bioentrepreneurship MBA: Options for mid-tier business schoolsPDF
Susan Malone Back

Join the Journal of Commercial Biotechnology discussion group on LinkedIn:

http://www.linkedin.com/groups?gid=1241807

This group focuses on the biotech industry. The audience and focus are the same as for the Journal of Commercial Biotechnology: Professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with the current issues and industry trends.

Topics include:

  • Corporate strategy
  • Financing
  • Bioethics
  • Public and investor relations
  • Market analysis
  • Legal and regulatory issues

While you’re at it, join my network too.

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4

Editorial

Continuing education in biotechnologyPDF
Yali Friedman

Articles

Can compliance help marketing and business development?PDF
John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiersPDF
Laura Heinonen, Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise itPDF
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practicePDF
Kerstin M Bode-Greuel, Klaus J Nickisch

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economiesPDF
Arlen D Meyers, Donald J McCubbrey, Richard T Watson

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: The Regulatory Challenge of BiotechnologyPDF
John Avellanet
Book Review: Intellectual Property and Biotechnology: Biological InventionsPDF
Stefan M Miller
Book Review: Commercializing Successful Biomedical TechnologiesPDF
Arlen D Meyers
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the BiosciencesPDF
Arlen D Meyers
Best Practices in Biotechnology Business DevelopmentPDF
Hans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop BiodiversityPDF
Drew L Kershen
Biotechnology and the LawPDF
Edward L Korwek
Welcome to Biotech NationPDF
James Rogers

The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and was guest-edited by Leyland Pitt and Ian McCarthy. The links below will take you to the abstract of each article:

Volume 14, Issue 3

Editorial

Connecting product innovation management and marketingPDF
Leyland Pitt, Ian McCarthy

Articles

New pharmaceutical product development: Barriers to overcome and opportunities to exploitPDF
Nic S Terblanche
The biotechnology and marketing interface: Functional integration using mechanistic and holographic responses to environmental turbulencePDF
Pierre Berthon, Leyland Pitt, Deon Nel, Esmail Salehi-Sangari, Anne Engstrom
Anticipating and managing the challenges of biotechnology marketingPDF
Heidi Rajamäki
A comparison of R&D indicators for the Vancouver biotechnology clusterPDF
Monica Salazar, Martin J Bliemel, J Adam Holbrook
Using brand personality to assess whether biotechnology firms are saying the right things to their networkPDF
Lisa Papania, Colin Campbell, Robert Ankomah Opoku, Maria Styven, Jean-Paul Berthon
Remembering Epimetheus: Biotechnologies and the marketPDF
Pierre Berthon, Ekin Pehlivan, Philip DesAutels
Networks of dedicated biotechnology and service firms in VancouverPDF
Martin J Bliemel, Ian P McCarthy

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:

Volume 14, Issue 2

Editorial

EditorialPDF
Yali Friedman

Articles

Export compliance for life sciencesPDF
John Avellanet
A new approach to improve technology commercialisation in university medical schoolsPDF
Courtney Price, Richard Huston, Arlen D Meyers
Biotechnology business models work: Evidence from the pharmaceutical marketplacePDF
J Leslie Glick
Valuing biotechnology companies: Does classification by technology type help?PDF
Jacqueline Loh, Robert Brooks
Risk management for the biotechnology industry: A Canadian perspectivePDF
Sandra Vanderbyl, Sherry Kobelak
Singapore’s biomedical sciences landscapePDF
Keat-Chuan Yeoh
Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpointPDF
Yoshihiro Okada, Kazuo N Watanabe

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Conference Report

Maryland and Virginia unite at 2007 Mid-Atlantic Bio ConferencePDF
Harley King

Book Reviews

Book Review: Stem cell wars: Inside stories from the FrontlinesPDF
Grant H Skrepnek

 

After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just been published. The links below will take you to each article:

Volume 14, Issue 1

Editorial

EditorialPDF
Yali Friedman

Articles

The ability to pick biotech talent: Being a better interviewer moves ‘you’ up the ladderPDF
David G Jensen
How the UN’s anti-biotech policies worsen global warmingPDF
Henry I Miller
Building a conducive environment for life science-based entrepreneurship and industry clustersPDF
Mark J Ahn, Michael Meeks
Cloning an industry: Strategy typologies of Shanghai biotechnology companiesPDF
Ken Malone, Brent Hales, Justin Chan, Monica Love, Jeremiah Rayner
Biotechnology in India: Public–private partnershipsPDF
Viren Konde
Biogenerics 2007: How far have we come?PDF
John Tucker, Seth Yakatan, Stan Yakatan
Monoclonal antibody therapeutics: Leading companies to maximise sales and market sharePDF
Karl Ziegelbauer, David R Light
Globalising clinical development in JapanPDF
Yorozu Tabata, Chris Albani

From the Classroom

Bioentrepreneurship education programmes in the United StatesPDF
Arlen D Meyers, Patrick Hurley

Legal and Regulatory Updates

Legal and regulatory updatePDF
John Wilkinson